SP-MHCI-1161-3

Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK

US$507.00

In stock

Description

About Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK

The Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin Peptide (IEDB: 2242079) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Hemagglutinin Peptide, H-SFERFEIFPK-OH (Uniprot: Q289M7 aa: 127-136) from JPT is produced under strict quality control and quality management.

Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK - Specifications

  • Peptide sequence: H-SFERFEIFPK-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Influenza
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK

References:
Read References with JPT’s Antigen Peptides
Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK has been described in:
Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response., Nat Immunol, 2023 (PMID: 37828378)

Documentation

Documentation for Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK

Properties

Properties of Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Influenza
Layout: Freeze-dried in glass vial
Organism: Influenza A
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Influenza A (strain A/New Zealand:South Canterbury/35/2000 H1N1) Hemagglutinin 127-136, SFERFEIFPK

Information Values
Sequence: H-SFERFEIFPK-OH
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote